Oragenics Inc. to Attend the Roth Capital 31st Annual Growth Conference March 17 - 19, 2019 March 15, 2019
Oragenics, Inc. Announces Publication Detailing the Development of Blueprints for Designing a New Class of Anti-Infectives November 27, 2018
Oragenics, Inc. Receives Clearance to Enroll Patients in Germany and the United Kingdom into Its Phase 2 Clinical Trial of AG013 for Oral Mucositis November 15, 2018
